First Omicron cases detected: 2 Karnataka samples show strain
đ´ Referring to the two cases of Omicron, ICMR chief Dr Balram Bhargava urged the public not to panic. The use of masks, maintaining hand hygiene, and not going to mass gatherings are key, he said.
At the international airport in Ahmedabad. (Express Photo)
The Union Health Ministry said Thursday that Omicron, the latest Covid variant of concern, has been detected for the first time in India in two cases from Karnataka through genomic surveillance.
The Ministry, however, stressed that there was no need to panic, called for strict adherence to Covid-appropriate behaviour and urged everyone to adopt the âuniversal vaccineâ of wearing masks to tackle the new challenge.
Youâve Read Your Free Stories For Now
Sign up and keep reading more stories that matter to you.
âTwo cases of the Omicron variant have been found positive. The first is a 66-year-old male and the other is a 46-year-old male⌠Mostly in all the cases related to Omicron, at present, the symptoms are mild. In the cases of Omicron detected in the country, we are not seeing any severe symptoms,â Lav Agarwal, Joint Secretary, Health Ministry, said.
Dr V K Paul, who heads the countryâs Covid task force, said India is following a two-pronged strategy. âFirst, we have increased our surveillance on international travel. We have (the strategy of) test, track and treat. Second, inside the country, we have to watch the new clusters, hospitalisations, cases, with higher intensity,â he said.
Paul also said that the scientific reasoning for providing booster doses is âunder examinationâ, although the focus is to first fully vaccinate the population.
Referring to the two cases of Omicron, Indian Council of Medical Research (ICMR) chief Dr Balram Bhargava urged the public not to panic. âThere is no need to panic. But awareness is absolutely essential. Covid-appropriate behaviour is required. The use of masks, hand hygiene, and not going to mass gatherings, will help break the chain of transmission of Omicron,â he said.
Responding to a question on the effectiveness of existing vaccines against the new variant, Bhargava said it is âprematureâ to take a call on the issue.
Story continues below this ad
âScientific understanding is that whole killed virion based vaccines may have a wider antigenic presentation and broad spectrum of effect against the new emergent variants. But we have detected only two Omicron cases and unless we isolate the virus, culture the virus, and test the virus in a laboratory setting, it is premature to comment on the effectiveness of the vaccine,â he said.
Whole killed virion based vaccines are those in which the virus is inactivated. When an inactivated vaccine enters the body, it makes antibodies at multiple target points.
Theoretically, such vaccines have the potential to target mutated coronavirus strains. Of the three vaccines deployed so far in India â Covishield, Covaxin and Sputnik â only Covaxin falls in this category.
Dr Paul, meanwhile, emphasised that vaccination remains âthe most critical toolâ. âWe are fortunate that we have that tool in plenty. There is no doubt we have to increase the coverage of vaccination. At this point, science tells us that we have to use vaccines. The new variant may dent the efficacy of the vaccine, to some extent. We said the same thing about Delta. It does not matter. We need to look at the big picture. Through full vaccination, we need to protect every individual. We cannot have any backlog of the second dose,â he said.
Story continues below this ad
Paul also said there is no requirement for any lockdown. Instead, he said, it is even more critical to strictly adopt the âuniversal vaccineâ of masks.
âThere should not be fear but responsibility. It is an unfolding situation. We are learning. But we are ready in every way. This is the mantra we will take forwardâŚThe countries that are taking masking very lightly are seeing a surge in cases. Masking is very important. People should avoid crowds and gather only in very well ventilated spaces,â he said.
Asked about the policy on booster doses, Paul said: âWe are closely studying the imperativesâŚIt is an ongoing exercise in our technical and scientific circles. All that is being carefully examined. As the situation unfolds and more scientific evidence emerges (on Omicron), we will take decisions in the future.â
On Wednesday, The Indian Express reported that health authorities in South Africa, where the first ever cases of Omicron were detected, have conveyed to experts in India that they are witnessing âvery low hospitalisationâ directly linked to the new variant â but it is âhighly transmissibileâ with patients experiencing extreme fatigue even with mild disease.
Story continues below this ad
The World Health Organisation (WHO) has assessed global risk from the newly discovered variant as âvery highâ.
As City Editor ( Delhi) at the Indian Express, Kaunain Sheriff leads city reporting with a sharp focus on accountability journalism, data-driven stories, and ground-level impact. As the National Health Editor he leads the newsroomâs in-depth coverage of pressing health issues.
He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, a definitive investigation into the accountability of one of the worldâs most powerful pharmaceutical corporations.
Areas of Expertise
Investigative Reporting: Has deep expertise in investigative reporting spanning public health, regulatory affairs, drug safety, and the criminal justice system. His work sits at the intersection of governance, law, and accountability, with a particular focus on how regulatory failures, institutional lapses, and policy decisions affect citizensâ rights and safety.
Data Journalism: Has extensively on big dataâdriven investigations, including analyses of flagship government schemes and large datasets on criminal trials, uncovering systemic gaps.
Global Collaborations
Kaunain is a key contributor to major international journalistic projects:
The Implant Files: Collaborated with the International Consortium of Investigative Journalists (ICIJ) to expose global malpractices in the medical device industry.
Chinese Big-Data Investigation: Uncovered how a foreign data firm monitored thousands of prominent Indian institutions and individuals in real-time.
Awards & Recognition
His commitment to "Journalism of Courage" has been recognized with the industry's highest honors:
Ramnath Goenka Award for Excellence in Journalism
SOPA Award (Society of Publishers in Asia)
Red Ink Award (Mumbai Press Club)
Indian Express Excellence Awards (Triple recipient for investigations into the NSA abuse in UP, Vyapam scam, and the anti-Sikh riots).
Education: Studied Mechanical Engineering at Visvesvaraya Technological University (VTU), Bangalore, before moving to Delhi to pursue his passion for journalism. His engineering training informs his analytical approach, enabling him to decode technical, legal, and data-heavy systems with precision.
Social media
LinkedIn:Â linkedin.com/in/kaunain-sheriff-3a00ab99
X ( fromerly Twitter): @kaunain_s ... Read More